Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI117998

Time series prediction of plasma hormone concentration. Evidence for differences in predictability of parathyroid hormone secretion between osteoporotic patients and normal controls.

K Prank, S J Nowlan, H M Harms, M Kloppstech, G Brabant, R D Hesch, and T J Sejnowski

Howard Hughes Medical Institute, Salk Institute, San Diego, California 92186-5800, USA.

Find articles by Prank, K. in: JCI | PubMed | Google Scholar

Howard Hughes Medical Institute, Salk Institute, San Diego, California 92186-5800, USA.

Find articles by Nowlan, S. in: JCI | PubMed | Google Scholar

Howard Hughes Medical Institute, Salk Institute, San Diego, California 92186-5800, USA.

Find articles by Harms, H. in: JCI | PubMed | Google Scholar

Howard Hughes Medical Institute, Salk Institute, San Diego, California 92186-5800, USA.

Find articles by Kloppstech, M. in: JCI | PubMed | Google Scholar

Howard Hughes Medical Institute, Salk Institute, San Diego, California 92186-5800, USA.

Find articles by Brabant, G. in: JCI | PubMed | Google Scholar

Howard Hughes Medical Institute, Salk Institute, San Diego, California 92186-5800, USA.

Find articles by Hesch, R. in: JCI | PubMed | Google Scholar

Howard Hughes Medical Institute, Salk Institute, San Diego, California 92186-5800, USA.

Find articles by Sejnowski, T. in: JCI | PubMed | Google Scholar

Published June 1, 1995 - More info

Published in Volume 95, Issue 6 on June 1, 1995
J Clin Invest. 1995;95(6):2910–2919. https://doi.org/10.1172/JCI117998.
© 1995 The American Society for Clinical Investigation
Published June 1, 1995 - Version history
View PDF
Abstract

Recent evidence links osteoporosis, a disease of bone remodeling, to changes in the dynamics of parathyroid hormone secretion. We use nonlinear and linear time series prediction to characterize the secretory dynamics of parathyroid hormone in both healthy human subjects and patients with osteoporosis. Osteoporotic patients appear to lack the periods of high predictability found in normal humans. Our results may provide an explanation for why an intermittent administration of parathyroid hormone is effective in restoring bone mass in osteoporotic patients.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 2910
page 2910
icon of scanned page 2911
page 2911
icon of scanned page 2912
page 2912
icon of scanned page 2913
page 2913
icon of scanned page 2914
page 2914
icon of scanned page 2915
page 2915
icon of scanned page 2916
page 2916
icon of scanned page 2917
page 2917
icon of scanned page 2918
page 2918
icon of scanned page 2919
page 2919
Version history
  • Version 1 (June 1, 1995): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts